Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riley Bove

Showing results (151-160 of 173) with videos related to

Pageof 18
Sort By:
AI Magazine|September 12, 2022
A biomedical open knowledge network harnesses the power of AI to understand deep human biologySergio E Baranzini, Katy Börner, John Morris, et al.
Nature Aging|February 22, 2024
Leveraging electronic health records and knowledge networks for Alzheimer's disease prediction and sex-specific biological insightsAlice S Tang, Katherine P Rankin, Gabriel Cerono, et al.
Medrxiv : the Preprint Server for Health Sciences|September 28, 2021
Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunityJoseph J Sabatino, Kristen Mittl, William Rowles, et al.
JAMA Neurology|September 16, 2024
Differential Diagnosis of Suspected Multiple Sclerosis in Pediatric and Late-Onset Populations: A ReviewLe H Hua, Andrew J Solomon, Silvia Tenembaum, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 27, 2022
Association of daily physical activity with brain volumes and cervical spinal cord areas in multiple sclerosisValerie J Block, Shuiting Cheng, Jeremy Juwono, et al.
Lancet (London, England)|May 28, 2026
Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b studyGavin Giovannoni, Laura Airas, Riley Bove, et al.
Multiple Sclerosis and Related Disorders|February 9, 2025
Does cognitive performance explain the gap between physiological and perceived fall-risk in people with multiple sclerosis?Tobia Zanotto, Danya Pradeep Kumar, Daniel Golan, et al.
Annals of Clinical and Translational Neurology|September 7, 2023
Anti-CD20 monoclonal antibody therapy in postpartum women with neurological conditionsAnnika Anderson, William Rowles, Shane Poole, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 30, 2022
Remote Observational Research for Multiple Sclerosis: A Natural ExperimentRiley Bove, Shane Poole, Richard Cuneo, et al.
NPJ Vaccines|May 17, 2025
Durable T cell immunity to COVID-19 vaccines in MS patients on B cell depletion therapyJulia Davis-Porada, Ceren Tozlu, Claudia Aiello, et al.
Pageof 18

Showing results (151-160 of 173) with videos related to

Sort By:
Pageof 18
AI Magazine|September 12, 2022
A biomedical open knowledge network harnesses the power of AI to understand deep human biologySergio E Baranzini, Katy Börner, John Morris, et al.
Nature Aging|February 22, 2024
Leveraging electronic health records and knowledge networks for Alzheimer's disease prediction and sex-specific biological insightsAlice S Tang, Katherine P Rankin, Gabriel Cerono, et al.
Medrxiv : the Preprint Server for Health Sciences|September 28, 2021
Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunityJoseph J Sabatino, Kristen Mittl, William Rowles, et al.
JAMA Neurology|September 16, 2024
Differential Diagnosis of Suspected Multiple Sclerosis in Pediatric and Late-Onset Populations: A ReviewLe H Hua, Andrew J Solomon, Silvia Tenembaum, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 27, 2022
Association of daily physical activity with brain volumes and cervical spinal cord areas in multiple sclerosisValerie J Block, Shuiting Cheng, Jeremy Juwono, et al.
Lancet (London, England)|May 28, 2026
Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b studyGavin Giovannoni, Laura Airas, Riley Bove, et al.
Multiple Sclerosis and Related Disorders|February 9, 2025
Does cognitive performance explain the gap between physiological and perceived fall-risk in people with multiple sclerosis?Tobia Zanotto, Danya Pradeep Kumar, Daniel Golan, et al.
Annals of Clinical and Translational Neurology|September 7, 2023
Anti-CD20 monoclonal antibody therapy in postpartum women with neurological conditionsAnnika Anderson, William Rowles, Shane Poole, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 30, 2022
Remote Observational Research for Multiple Sclerosis: A Natural ExperimentRiley Bove, Shane Poole, Richard Cuneo, et al.
NPJ Vaccines|May 17, 2025
Durable T cell immunity to COVID-19 vaccines in MS patients on B cell depletion therapyJulia Davis-Porada, Ceren Tozlu, Claudia Aiello, et al.
Pageof 18